title: Cavum septum pellucidum and cavum vergae with late-onset catatonia.
abstract: Associations between large cavum septum pellucidum and functional psychosis disorders, especially schizophrenia, have been reported. We report a case of late-onset catatonia associated with enlarged CSP and cavum vergae. A 66-year-old woman was presented with altered mental status and stereotypic movement. She was initially treated with aripiprazole and lorazepam. After 4 weeks, she was treated with electroconvulsive therapy. By 10 treatments, echolalia vanished, and catatonic behavior was alleviated. Developmental anomalies in the midline structure may increase susceptibility to psychosis, even in the elderly.
authors.affiliation: Department of Psychiatry, Shinshu University School of Medicine, Japan.
authors.forename: Takehiko
authors.initials: T
authors.lastname: Yasaki
authors.forename: Yuka
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Tohru
authors.initials: T
authors.lastname: Takahashi
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Washizuka
authors.forename: Naoji
authors.initials: N
authors.lastname: Amano
authors.forename: Tokiji
authors.initials: T
authors.lastname: Hanihara
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D001921:Brain / Q000473:pathology; D002389:Catatonia / Q000209:etiology*; D003545:Cysteine / Q000031:analogs & derivatives; D004565:Electroconvulsive Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D015609:Organotechnetium Compounds; D010879:Piperazines / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D019275:Radiopharmaceuticals; D012688:Septum Pellucidum / Q000000981:diagnostic imaging / Q000473:pathology*; D013001:Somatoform Disorders / Q000150:complications; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D015609:Organotechnetium Compounds; D010879:Piperazines; D015363:Quinolones; D019275:Radiopharmaceuticals; D000068180:Aripiprazole; C059659:technetium Tc 99m bicisate; D003545:Cysteine; D008140:Lorazepam